Fortis Pharma Consulting Limited - Limited company - abbreviated - 11.0.0

REGISTERED NUMBER: 05390470 (England and Wales)

Abbreviated Unaudited Accounts for the Year Ended 31 March 2014

for

Fortis Pharma Consulting Limited

Page

Company Information

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

4

Chartered Accountants' Report

6

DIRECTORS:

G Smith

M Stanton

SECRETARY:

S Bennett

REGISTERED OFFICE:

22 Great James Street

London

WC1N 3ES

REGISTERED NUMBER:

05390470 (England and Wales)

ACCOUNTANTS:

Caroline Gibbons ACA CTA

26 Eastwick Drive

Great Bookham

Leatherhead

Surrey

KT23 3PR

FIXED ASSETS

Intangible assets

2

75,625

82,500

Tangible assets

3

4,851

2,268

80,476

84,768

CURRENT ASSETS

Debtors

4

627,544

657,835

Cash at bank and in hand

156,807

177,453

784,351

835,288

CREDITORS

Amounts falling due within one year

162,938

187,130

NET CURRENT ASSETS

621,413

648,158

TOTAL ASSETS LESS CURRENT LIABILITIES

701,889

732,926

PROVISIONS FOR LIABILITIES

970

-

NET ASSETS

700,919

732,926

CAPITAL AND RESERVES

Called up share capital

5

2

2

Profit and loss account

700,917

732,924

SHAREHOLDERS' FUNDS

700,919

732,926

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2014 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 21 November 2014 and were signed on its behalf by:

G Smith - Director

M Stanton - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in accordance with the

Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover

Turnover represents net invoiced sales of goods, excluding value added tax, except in respect of service contracts

where turnover is recognised when the company obtains the right to consideration.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2005, is being amortised evenly over its estimated useful life of twenty years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

33% on cost and 25% on cost

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension

scheme are charged to the profit and loss account in the period to which they relate.

2.	INTANGIBLE FIXED ASSETS

Total

£

COST

At 1 April 2013

and 31 March 2014

137,500

AMORTISATION

At 1 April 2013

55,000

Amortisation for year

6,875

At 31 March 2014

61,875

NET BOOK VALUE

At 31 March 2014

75,625

At 31 March 2013

82,500

3.	TANGIBLE FIXED ASSETS

Total

£

COST

At 1 April 2013

3,870

Additions

6,505

Disposals

(1,001

)

At 31 March 2014

9,374

DEPRECIATION

At 1 April 2013

1,602

Charge for year

3,922

Eliminated on disposal

(1,001

)

At 31 March 2014

4,523

NET BOOK VALUE

At 31 March 2014

4,851

At 31 March 2013

2,268

4.

DEBTORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

The aggregate total of debtors falling due after more than one year is £ 525,523 (31.3.13 - £ 526,836 )

5.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.3.14

31.3.13

value:

£

£

2

Ordinary

£1

2

2

6.	ULTIMATE PARENT COMPANY

Azimuth Pharma Ltd is regarded by the directors as being the company's ultimate parent company.

The following reproduces the text of the report prepared for the directors in respect of the company's annual

unaudited financial statements, from which the unaudited abbreviated accounts (set out on pages two to five)

have been prepared.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the

financial statements of Fortis Pharma Consulting Limited for the year ended 31 March 2014 which comprise the Profit

and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information

and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject

to its ethical and other professional requirements which are detailed at icaew.com/membershandbook.

This report is made solely to the Board of Directors of Fortis Pharma Consulting Limited, as a body, in accordance with

our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of

Fortis Pharma Consulting Limited and state those matters that we have agreed to state to the Board of Directors of Fortis

Pharma Consulting Limited, as a body, in this report in accordance with AAF 2/10 as detailed at icaew.com/compilation.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and

its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Fortis Pharma Consulting Limited has kept adequate accounting records and to prepare

statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Fortis

Pharma Consulting Limited. You consider that Fortis Pharma Consulting Limited is exempt from the statutory audit

requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Fortis Pharma Consulting

Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and

explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Caroline Gibbons ACA CTA

26 Eastwick Drive

Great Bookham

Leatherhead

Surrey

KT23 3PR

21 November 2014